Page 6 - Best Chemotherapy Chemotherapy: TOP 156 doctors

Internationally recognized pediatric oncology expert – Prof. Ben-Harush leads the Pediatric Division at Ruth Rappaport Children's Hospital.

• Specializes in pediatric oncology and bone marrow transplantation
• Recipient of the Chevalier de la Legion d'Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of children's oncology groups in the USA and Europe

Radiotherapy specialist with a dedicated focus on oncology at Rambam Medical Center.

• Specializes in chemotherapy and radiotherapy treatments
• Works at Rambam Medical Center, a leading healthcare institution
• Committed to personalized cancer care plans

Head of the Breast Cancer Treatment Center – Prof. Jablonski-Perec brings decades of specialized expertise to Hadassah Medical Center.

• Received medical training at Sloan-Kettering Cancer Center in New York
• Professor of Oncology at Hebrew University since 2006
• Former Head of the Institute of Oncology
• Member of multiple international cancer societies

Dr. Spielberg is a specialized oncohematologist treating patients at Assuta Medical Center.

• Focuses exclusively on chemotherapy treatments
• Works at one of Israel's leading medical centers
• Dedicated to personalized treatment plans for each patient

Dr. Zhevelyuk specializes in oncology and radiology at Assuta Medical Center.

• Experienced in chemotherapy treatments
• Works at a leading medical center
• Focuses on patient-centered care

Chief Physician of the Oncology Center at Assuta Medical Center – leading expert in chemotherapy treatments.

• Specializes in oncology with extensive experience in chemotherapy protocols
• Holds a leadership role at a top-tier medical center
• Dedicated to personalized treatment plans for each patient

Specializes in breast cancer and melanoma treatments, focusing on hormone therapy resistance and immunotherapy. Works at Hospital Quiron Barcelona.

• Participated in trials leading to new drug approvals for breast cancer
• Involved in studies that revolutionized melanoma treatment
• Member of Breast Cancer and Melanoma Units at Vall d’Hebron
• Focuses on holistic patient care

Principal Investigator in clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin leads groundbreaking research at Hospital Quiron Barcelona.

• Author of 100+ publications on gynecological tumors
• Executive board member of GEICO Group (Spanish Ovarian Cancer Research Group)
• Faculty member for Gyn-Track in ESMO
• Spanish representative in GCIG Group's Cervical Committee

Leading expert in chronic lymphocytic leukemia (CLL) – Professor Bosch has pioneered new treatments and technologies for hematological diseases.

• Conducts over 80 clinical trials from phase 1 to phase 3
• Published more than 100 articles in top medical journals
• Head of Hematology at IOB Institute of Oncology
• President of the Spanish group for CLL study (GELLC)

Prof. Ben Boursi leads research on microbiome prognostic factors in cancer therapies – merging cutting-edge science with clinical oncology at Sheba Medical Center.

• Specializes in gastrointestinal cancers with focused training at University of Pennsylvania and MD Anderson
• Founder of ECOG-ACRIN Microbiome Working Group – pioneering microbial modulation treatments
• Develops predictive models for colorectal and pancreatic cancers undergoing clinical trials
• Board-certified in both Internal Medicine and Medical Oncology by Israeli medical boards
• Teaches host-microbiome interactions at Tel Aviv University's medical school

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Assoc. Prof. Dr. Iyikesici specializes in metabolically supported chemotherapy – a tailored approach combining traditional methods with metabolic therapies at Central Hospital.

• Focuses on breast, lung, and gastrointestinal cancers
• Pioneers metabolic therapies like ketogenic diet in treatment plans
• Published peer-reviewed research on cancer treatment outcomes
• Offers hyperthermia and hyperbaric oxygen as complementary therapies

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Assoc. Prof. Murat Ayhan leads cutting-edge chemotherapy research at Liv Hospital Vadistanbul, with multiple international clinical trials.

• Specializes in breast, lung, and colorectal cancers
• Active in Phase II and III clinical trials for novel treatments
• Published 25+ research papers in peer-reviewed oncology journals
• Member of ESMO and Turkish Society of Medical Oncology

Dr. Apak specializes in pediatric hematology-oncology with 26 years of experience of experience, including bone marrow transplantation and CAR T-cell therapy at Biruni University Hospital.

• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Authored 75 international publications in pediatric oncology
• Assistant editor for Turkish Pediatrics Archives Periodical
• Board member of Turkish Pediatric Society and Turkish Adolescent Association

Associate Professor of Hematology with 50+ publications – Dr. Eren is a specialist in hematologic oncology at Biruni University Hospital.

• Expert in chemotherapy for hematologic malignancies
• Member of European Society of Hematology
• Winner of multiple research awards in hematology
• Speaks English fluently

Specializes in chronic leukemia, lymphoma, and multiple myeloma – Dr. Dogu brings deep expertise in hematologic cancers to Liv Hospital Ulus.

• 36 years of experience of experience in hematology and internal medicine
• Published 32 articles in international peer-reviewed journals
• Board member of The Society of Hematological Education and Research
• Associate Professor at Istanbul Training and Research Hospital